Morocco Actively Participates in WHA's 78th Session in Geneva
Morocco's delegation to the 78th session of the World Health Assembly (WHA), taking place in Geneva from May 19 to 27, has been involved in a series of intensive bilateral and multilateral engagements as part of this major global health event.
Morocco's active participation reflects the Kingdom's ongoing commitment to international efforts aimed at building more resilient, equitable, and sustainable health systems, in line with the High Directives of His Majesty King Mohammed VI, Minister of Health and Social Protection, Amine Tehraoui, told MAP.
Speaking during the Assembly's plenary sessions, the official delivered both the address on behalf of the Francophone Group and Morocco's national statement. He highlighted the major structural health reforms initiated under the leadership of His Majesty King Mohammed VI.
In his remarks, Tehraoui stressed that 'the pace of global change calls for a redefinition of healthcare priorities, with a clear focus on achieving universal health coverage and enhancing the resilience and sustainability of health systems—especially in light of challenges such as climate change.'
He also welcomed the approval of the WHO's pandemic agreement on Tuesday, describing it as 'a strong sign of our collective ability to rise above differences and work together for the health of all.'
The Moroccan delegation participated in a series of parallel strategic meetings, including the Council of Arab Health Ministers, a high-level session on sustainable health financing organized with Africa CDC, and an event on local drug production.
The minister also co-chaired a high-level side event devoted to the presentation of a draft resolution aimed at strengthening and promoting the global health workforce by 2030.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Morocco World
a day ago
- Morocco World
Moroccan Biologist Jinane Zouaki Joins Ibero-American Academy of Pharmacy
Rabat – Moroccan biologist Jinane Zouaki has been appointed as an academic corresponding member of the Ibero-American Academy of Pharmacy. Her appointment marks a big milestone, as she is the first Moroccan, Arab, and African woman to receive this honor. The official ceremony took place on Tuesday at the Faculty of Pharmacy in Granada, Spain. The event gathered many scientists from Spain, Portugal, Latin America, and Morocco. In her speech to the academy, Zouaki spoke about her history of pharmacy in Morocco. She outlined the country's recent efforts to strengthen its health sovereignty under the leadership of King Mohammed VI. She explained that this national strategy has helped Morocco become a leading industrial hub and a strong, competitive player in both regional and international healthcare sectors. Speaking to Morocco's state news agency MAP, Zouaki shared her pride and gratitude for joining such a prestigious institution. She said the recognition is not only a personal achievement, but also a proud moment for Moroccan women and for the country as a whole. This recognition contributes to Morocco's scientific presence on the international stage, she added. Originally from the northern city of Tetouan, Zouaki holds a doctorate in pharmacy. In 2022, she became the first Moroccan and African to receive the Medal of Privilege from the University of Granada, a high honor that celebrates her long journey in education and biomedical research. Zouaki also made history as the first Moroccan to join the Royal Academy of Pharmacy of Catalonia. During the COVID-19 pandemic, she volunteered to help medical teams. At her molecular biology lab in Saniat Rmel Hospital in Tetouan, she worked on COVID-19 testing and helped train healthcare workers. Tags: HealthMoroccopharmacy
Morocco World
6 days ago
- Morocco World
UM6P Partners with ANRAC to Boost Medical Cannabis Research in Morocco
Rabat – The Mohammed VI Polytechnic University (UM6P) and the National Agency for the Regulation of Cannabis-Related Activities (ANRAC) have signed a partnership agreement to work together on research into the medical and pharmaceutical uses of cannabis in Morocco. This collaboration will focus on scientific research using tested medical methods to study how cannabis can be used to treat health problems, UM6P said in a press release. The goal is to better understand the active compounds in cannabis and how they might help treat certain illnesses safely and effectively. The researchers will use tools like laboratory testing, computer modeling, and data analysis to learn more about how cannabis might work in medical treatments. They will follow strict health and safety rules throughout the research, added the statement. The agreement also includes plans to share research results with professionals in the health, pharmacy, and clinical research sectors. This is to ensure that any scientific discoveries can be used in real-life treatments under proper supervision. In addition to research, the partnership will offer training programs for doctors, pharmacists, researchers, and other healthcare professionals. These courses will teach about how cannabis works in the body, the legal rules for using it, and how to include cannabis-based treatments in patient care. A separate agreement was also signed with the African Genome Center at UM6P to support a special project on studying the local cannabis variety called 'Beldia' using advanced genetic tools. The aim is to understand this local plant better and make sure it is protected and traceable. This entire initiative is part of a bigger plan to build strong scientific knowledge about medical cannabis in Morocco. It brings together science, health care, legal standards, and ethics to develop safe and well-regulated medical uses for cannabis in the country, concluded the statement. In recent years, Morocco has undertaken several regulatory reforms to transition its long-standing cannabis economy toward a legal, controlled system. In 2021, the Moroccan parliament passed a law permitting the cultivation of cannabis strictly for medical, cosmetic, and industrial purposes. To enforce this, the government established the ANRAC, tasked with licensing farmers, processing facilities, exporters, and controlling THC thresholds, seed certification, traceability, and security across approved zones in the Rif region. Between 2022 and 2024, ANRAC issued thousands of licenses covering cultivation on more than 2,700 hectares, with legal production topping 4,000 tonnes. To incentivize transition, King Mohammed VI in August 2024 pardoned nearly 4,800 farmers convicted of illicit cannabis cultivation and helped them access the legal market.
Maroc
18-06-2025
- Maroc
Casablanca's Cheikh Khalifa Hospital Performs First Robotic Surgery
The Cheikh Khalifa International University Hospital in Casablanca has performed its first robotic surgery, the hospital said on Tuesday, marking a milestone in the facility's adoption of advanced surgical technologies. The procedure, a prostatectomy, was conducted by a fully Moroccan medical team led by Professor Abdejalil Heddat, a urological surgery specialist, using the Da Vinci surgical system — a globally recognized robotic platform known for its precision and minimally invasive capabilities. The hospital said the robot-assisted surgery provides enhanced visualisation and precision for surgeons, while reducing incision size, blood loss, and patient recovery time. 'This first robotic procedure represents a significant advancement in our hospital's development,' said Professor Khalid Sair, General Director of the hospital and a general surgery specialist. 'It is the result of extensive training and preparation of our surgical teams.' Beyond urology, the hospital plans to expand the use of robotic surgery to other specialties, including colorectal, pancreatic, hepatic, gastric, thoracic, and gynecological procedures, with potential applications in ENT and cardiovascular surgery, Sair added. The introduction of robotic surgery forms part of the hospital's broader strategy to modernize its infrastructure and improve healthcare quality through technology-driven innovation.
